Latest in News & Research
Daily Emollient Application May Reduce Risk for Atopic Dermatitis in Infants
Daily emollient applications starting before age 9 weeks linked to reduction in cumulative incidence of atopic dermatitis at age 24 months
Factors Identified That Affect Dermoscopic Findings in Acral Melanoma
Tumor thickness, lesion diameter, patient sex, and patient age may affect dermoscopic findings
Study Compares Benefits, Harms of Treatments for Chronic Hives
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions
Subclinical Synovitis Risk Higher in Psoriasis Without Musculoskeletal Involvement
Authors say imaging may aid in identifying individuals at risk for progression to psoriatic arthritis
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
80 percent of adult patients with stage III/IV resectable melanoma remained event-free at four years from the start of neoadjuvant systemic treatment
Number of Atopic Dermatitis Flares Linked to Lower QoL, More Severe Disease
Flare severity, duration, and number were among most important predictors of AD severity
Neutrophil-to-Lymphocyte Ratio Can ID Risk in Localized Melanoma
NLR level >4.8 associated with increased risk for melanoma-specific death and developing distant metastases
High Dietary Inflammatory Index Tied to Increased Prevalence of Eczema
Significant sex interaction observed, with stronger associations in the female group
Atopic Dermatitis May Be Linked to Increased Risk for CKD
Association between AD and increased risk for chronic kidney disease seen for men and women and in all age groups
Prevalence, Incidence of Eczema Increase With Severity of Alopecia Areata
Those with moderate-to-severe versus mild AA had 78 percent higher risk for being diagnosed with atopic dermatitis
Ichthyosis Scoring System Can Be Applied Across Phototypes
Excellent interrater intraclass correlation coefficients seen for individuals with Fitzpatrick I to III, IV to VI skin types
Distinct Risk Factors Seen for Nevus-Associated, De Novo Melanomas
Significantly higher hazard ratios seen for NAM than de novo melanoma for high nevus density, high genetic propensity for melanoma development
AI Better for Tumor-Infiltrating Lymphocyte Quantification in Melanoma Than Traditional Methods
Machine learning algorithm has superior reproducibility and prognostic associations compared with traditional pathologist-read methods
Review Compares Efficacy, Safety of Treatments for Hidradenitis Suppurativa
Differences between adalimumab and other targeted treatments mainly not significant
Extending Dabrafenib + Trametinib Beneficial in Stage III Melanoma
Extending adjuvant dabrafenib + trametinib beyond one year linked to better relapse-free survival
Increased Levels of Environmental Pollutants Linked to Atopic Dermatitis
Probable associations seen for secondhand smoking exposure and traffic and industrial plant exposure with increased prevalence of atopic dermatitis
Men With Hidradenitis Suppurativa Perceive Better Physician Communication
Female patients perceive that clinicians are significantly worse at demonstrating respect, listening, and explaining concepts
Nearly 30 People in England Get Rare Illness After Botox
Key Takeaways
- Dozens of people in England got botulism after Botox procedures
- Botulism can be life-threatening
- Officials are also looking into illegal sales of...
FDA Approves Once-Monthly Andembry for Hereditary Angioedema
The monoclonal antibody is a self-administered injection for prophylactic use to prevent attacks
'Clefting' Linked to Malignancy in Melanocytic Lesions
Clefting identified in 40 percent of melanomas and 6 percent of benign lesions
Povorcitinib Leads to Substantial Repigmentation in Nonsegmental Vitiligo
Significant improvement seen in total-Vitiligo Area Scoring Index from baseline at week 24 for povorcitinib versus placebo
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa
One-time surgical application of prademagene zamikeracel improves wound healing and pain
FDA Approves Dupixent for Bullous Pemphigoid
Benefits include sustained disease remission, reductions in itch, lower oral corticosteroids dose
24 of 1200